Skip to main content

Table 4 Echocardiographic measurements and ecNOS4a/b genotypes in hypertensive patients included in echocardiographic substudy

From: Negative association of endothelial nitric oxide gene polymorphism with hypertension in Turkish patients: effect of ecNOS polymorphism on left ventricular hypertrophy

Variable

ecNOS4a/b polymorphism

 
 

a/a

a/b

b/b

p

LVEDD

27.22(2.93)

27.72(4.53)

27.65(5.03)

0.93

LVESD

17.44(3.25)

18.61(5.18)

18.32(5.26)

0.89

IVS, mm

14.83(1.6)

11.91(1.51)

12.21(1.56)

0.0001

PW, mm

12.17(1.94)

10.95(1.43)

10.74(1.51)

0.92

LV EF, %

65.33(8.45)

60.82(14.61)

61.97(14.33)

0.78

LV FS, %

36.17(7.11)

33.14(10.22)

34.06(9.69)

0.78

LVMI, g/m2

173.5(27.29)

141.77(37.31)

151.78(56.32)

0.39

LVH, %

100

77.3

72.3

X2 = 2.23

p = 0.31

E, cm/s

57(26.06)

64.53(21.06)

72.05(24.3)

0.33

A, cm/s

96(16.64)

77.94(13.75)

80.93(26.77)

0.49

LA size, mm

43(12.81)

39.5(6.26)

37.26(5.42)

0.56

  1. LVEDD: left ventricular end-diastolic dimension mm/m2, LVESD: left ventricular end-systolic dimension mm/m2, IVS: interventricular septal thickness mm/m2, PW: posterior wall thickness mm/m2, LV FS: left ventricular fractional shortening, LVMI: left ventricular mass index (Penn formula), E: early diastolic transmitral peak velocity, A: late diastolic transmitral peak velocity, LA: left atrium size mm.